Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

By afschroeder • October 22, 2025

Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R, Martel BC, Røpke MA, Katoh N, Alexis AF. Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. Am J Clin Dermatol. 2025 Oct 21. doi: 10.1007/s40257-025-00985-1. Epub ahead of print. PMID: 41118053.

Tags: Dermatology, Publications

Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder

Kasperkiewicz M, Ludwig RJ, Curman P. Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder. J Eur Acad Dermatol Venereol. 2025 Oct 17. doi:[...]

Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review

Modanlo N, Cheng K, Nguyen MO, Truong A. Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review. J Am Acad Dermatol. 2025 Oct 17:S0190-9622(25)03025-7. doi: 10.1016/j.jaad.2025.10.055.[...]

Educating Dermatologists for the Artificial Intelligence Era

Wongvibulsin S, Lee I. Educating Dermatologists for the Artificial Intelligence Era. Dermatol Clin. 2025 Oct;43(4):593-601. doi: 10.1016/j.det.2025.05.010. Epub 2025 Jul 14. PMID: 41093481.